FDA Inspection
Janssen Biotech, Inc.Janssen Biotech, Inc. – FDA Inspection, Feb 27, 2017
Record Details
This FDA Inspection record concerns Janssen Biotech, Inc., with an inspection on February 27, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 351b5c60-a476-40a2-a8d9-bd8135ee2f6c
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1007329
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Janssen Biotech, Inc.
14| Date | Classification | Office | Project area |
|---|---|---|---|
| July 29, 2025 | Not classified | Philadelphia District Office | |
| March 10, 2025 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 30, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 5, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 21, 2017 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Janssen Biotech, Inc.
- FDA Inspection 1276933 - 2025-07-29
- FDA Inspection 1265723 - 2025-03-10
- FDA Inspection 1077487 - 2018-11-30
- FDA Inspection 1046499 - 2018-03-05
- FDA Inspection 1031776 - 2017-11-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.